Microarray Technology

Vaxess rebrands to Terrestrial Bio, raises $50M for GLP-1 patch

Vaxess Technologies today announced a rebranding to Terrestrial Bio, Inc., along with $50 million in Series C financing.

一部の結果でアクセス不可の可能性があるため、非表示になっています。